闭幕社论：结直肠癌——分子遗传学视角
Closing Editorial: Colorectal Cancer-A Molecular Genetics Perspective.
作者信息
Gharib Ehsan
机构信息
Département de Chimie et Biochimie, Université de Moncton, Moncton, NB E1A 3E9, Canada.
Atlantic Cancer Research Institute, Moncton, NB E1C 8X3, Canada.
出版信息
Int J Mol Sci. 2024 Nov 24;25(23):12604. doi: 10.3390/ijms252312604.
Abstract
Colorectal cancer (CRC) remains a significant global health challenge, ranking third in incidence and second in mortality among all cancers [...].
摘要
结直肠癌（CRC）仍然是一项重大的全球健康挑战，在所有癌症中的发病率排名第三，死亡率排名第二 [...]。
相似文献
1
Closing Editorial: Colorectal Cancer-A Molecular Genetics Perspective.闭幕社论：结直肠癌——分子遗传学视角
Int J Mol Sci. 2024 Nov 24;25(23):12604. doi: 10.3390/ijms252312604.
2
Epigenetic Alteration in Colorectal Cancer: Potential Diagnostic and Prognostic Implications.结直肠癌中的表观遗传改变：潜在的诊断和预后意义。
Int J Mol Sci. 2024 Mar 15;25(6):3358. doi: 10.3390/ijms25063358.
3
Significant position of C-myc in colorectal cancer: a promising therapeutic target.C-myc 在结直肠癌中的重要地位：一个有前途的治疗靶点。
Clin Transl Oncol. 2022 Dec;24(12):2295-2304. doi: 10.1007/s12094-022-02910-y. Epub 2022 Aug 16.
4
Genetics of colorectal cancer.结直肠癌的遗传学
MedGenMed. 2004 Aug 13;6(3):13.
5
Colorectal Cancer: Epidemiology, Risk Factors, and Public Health Strategies.结直肠癌：流行病学、风险因素及公共卫生策略
Digestion. 2025;106(2):91-99. doi: 10.1159/000543921. Epub 2025 Feb 12.
6
[Molecular Pathogenesis of Colorectal Cancer].[结直肠癌的分子发病机制]
Klin Onkol. 2016 Winter;29(6):419-427. doi: 10.14735/amko2016419.
7
Second primary cancers after sporadic and familial colorectal cancer.散发性和家族性结直肠癌后的第二原发性癌症。
Cancer Epidemiol Biomarkers Prev. 2001 Jul;10(7):793-8.
8
Cellular senescence: a promising therapeutic target in colorectal cancer.细胞衰老：结直肠癌有前途的治疗靶点。
Future Oncol. 2022 Sep;18(30):3463-3470. doi: 10.2217/fon-2021-0661. Epub 2022 Sep 7.
9
Dysregulation of DNA methylation in colorectal cancer: biomarker, immune regulation, and therapeutic potential.结直肠癌中DNA甲基化失调：生物标志物、免疫调节及治疗潜力
Int Immunopharmacol. 2025 Jan 3;145:113766. doi: 10.1016/j.intimp.2024.113766. Epub 2024 Dec 6.
10
Host genetics-associated mechanisms in colorectal cancer.结直肠癌的宿主遗传学相关机制。
Adv Genet. 2024;112:83-122. doi: 10.1016/bs.adgen.2024.08.003. Epub 2024 Sep 27.
引用本文的文献
1
Food Preservatives and the Rising Tide of Early-Onset Colorectal Cancer: Mechanisms, Controversies, and Emerging Innovations.食品防腐剂与早发性结直肠癌的上升趋势：作用机制、争议及新出现的创新方法
Foods. 2025 Sep 1;14(17):3079. doi: 10.3390/foods14173079.
本文引用的文献
1
Exploring the gut microbiome's role in colorectal cancer: diagnostic and prognostic implications.探讨肠道微生物组在结直肠癌中的作用：诊断和预后意义。
Front Immunol. 2024 Oct 17;15:1431747. doi: 10.3389/fimmu.2024.1431747. eCollection 2024.
2
Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy.涉及结直肠癌的信号通路：发病机制和靶向治疗。
Signal Transduct Target Ther. 2024 Oct 7;9(1):266. doi: 10.1038/s41392-024-01953-7.
3
A Systematic Review of Diagnostic Performance of Circulating MicroRNAs in Colorectal Cancer Detection with a Focus on Early-Onset Colorectal Cancer.循环 microRNAs 在结直肠癌检测中的诊断性能的系统评价：重点关注早发性结直肠癌。
Int J Mol Sci. 2024 Sep 3;25(17):9565. doi: 10.3390/ijms25179565.
4
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies.从隐窝到癌症：结直肠癌发生和治疗策略的整体观点。
Int J Mol Sci. 2024 Aug 30;25(17):9463. doi: 10.3390/ijms25179463.
5
Could environmental exposure and climate change Be a key factor in the rising incidence of early onset colorectal cancer?环境暴露和气候变化会是早发性结直肠癌发病率上升的关键因素吗？
Heliyon. 2024 Aug 10;10(16):e35935. doi: 10.1016/j.heliyon.2024.e35935. eCollection 2024 Aug 30.
6
Machine learning-based analysis identifies and validates serum exosomal proteomic signatures for the diagnosis of colorectal cancer.基于机器学习的分析鉴定和验证了用于结直肠癌诊断的血清外泌体蛋白质组学特征。
Cell Rep Med. 2024 Aug 20;5(8):101689. doi: 10.1016/j.xcrm.2024.101689.
7
Patient-derived organoids (PDOs) and PDO-derived xenografts (PDOXs): New opportunities in establishing faithful pre-clinical cancer models.患者来源的类器官（PDO）和PDO衍生的异种移植物（PDOX）：建立可靠的临床前癌症模型的新机遇。
J Natl Cancer Cent. 2022 Oct 22;2(4):263-276. doi: 10.1016/j.jncc.2022.10.001. eCollection 2022 Dec.
8
Immune checkpoint inhibitors in colorectal cancer: limitation and challenges.结直肠癌中的免疫检查点抑制剂：局限性与挑战
Front Immunol. 2024 Jun 11;15:1403533. doi: 10.3389/fimmu.2024.1403533. eCollection 2024.
9
Tumor mutational burden in colorectal cancer: Implications for treatment.结直肠癌的肿瘤突变负担：治疗意义。
Crit Rev Oncol Hematol. 2024 May;197:104342. doi: 10.1016/j.critrevonc.2024.104342. Epub 2024 Apr 12.
10
The Construction of a Multi-Gene Risk Model for Colon Cancer Prognosis and Drug Treatments Prediction.构建用于结肠癌预后和药物治疗预测的多基因风险模型。
Int J Mol Sci. 2024 Apr 2;25(7):3954. doi: 10.3390/ijms25073954.
Zotero 插件